INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 228 filers reported holding INSMED INC in Q1 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,997,409 | +21.6% | 1,346,432 | +1.7% | 0.01% | +40.0% |
| Q2 2023 | $27,948,153 | +25.8% | 1,324,557 | +1.6% | 0.01% | +25.0% |
| Q1 2023 | $22,224,369 | -14.5% | 1,303,482 | +0.2% | 0.00% | -20.0% |
| Q4 2022 | $25,990,882 | +4.4% | 1,300,845 | +12.6% | 0.01% | -16.7% |
| Q3 2022 | $24,885,000 | +8.8% | 1,155,328 | -0.4% | 0.01% | +20.0% |
| Q2 2022 | $22,869,000 | -17.8% | 1,159,673 | -2.1% | 0.01% | 0.0% |
| Q1 2022 | $27,836,000 | -16.4% | 1,184,518 | -3.1% | 0.01% | 0.0% |
| Q4 2021 | $33,307,000 | +0.7% | 1,222,716 | +1.8% | 0.01% | -16.7% |
| Q3 2021 | $33,079,000 | +1.0% | 1,201,140 | +4.3% | 0.01% | 0.0% |
| Q2 2021 | $32,761,000 | -13.8% | 1,151,123 | +3.2% | 0.01% | -14.3% |
| Q1 2021 | $37,994,000 | -1.8% | 1,115,503 | -4.0% | 0.01% | -12.5% |
| Q4 2020 | $38,672,000 | +1.3% | 1,161,620 | -2.2% | 0.01% | 0.0% |
| Q3 2020 | $38,194,000 | +9.3% | 1,188,354 | -6.4% | 0.01% | 0.0% |
| Q2 2020 | $34,955,000 | +101.7% | 1,269,228 | +17.4% | 0.01% | +60.0% |
| Q1 2020 | $17,330,000 | -31.9% | 1,081,096 | +1.5% | 0.01% | -16.7% |
| Q4 2019 | $25,436,000 | +29.0% | 1,065,152 | -4.7% | 0.01% | +20.0% |
| Q3 2019 | $19,722,000 | -21.3% | 1,117,982 | +14.3% | 0.01% | -16.7% |
| Q2 2019 | $25,048,000 | -9.2% | 978,451 | +3.1% | 0.01% | -14.3% |
| Q1 2019 | $27,577,000 | +123.7% | 948,654 | +1.0% | 0.01% | +133.3% |
| Q4 2018 | $12,327,000 | -39.5% | 939,621 | -6.8% | 0.00% | -40.0% |
| Q3 2018 | $20,376,000 | -12.7% | 1,007,742 | +2.1% | 0.01% | -16.7% |
| Q2 2018 | $23,348,000 | +8.3% | 987,228 | +3.1% | 0.01% | 0.0% |
| Q1 2018 | $21,555,000 | -27.5% | 957,164 | +0.3% | 0.01% | -25.0% |
| Q4 2017 | $29,746,000 | +0.5% | 953,984 | +0.6% | 0.01% | 0.0% |
| Q3 2017 | $29,590,000 | +108.9% | 948,115 | +14.8% | 0.01% | +100.0% |
| Q2 2017 | $14,167,000 | -0.6% | 825,617 | +1.4% | 0.00% | 0.0% |
| Q1 2017 | $14,255,000 | +37.4% | 814,078 | +3.8% | 0.00% | +33.3% |
| Q4 2016 | $10,376,000 | -6.0% | 784,294 | +3.1% | 0.00% | 0.0% |
| Q3 2016 | $11,042,000 | +49.1% | 760,407 | +1.2% | 0.00% | +50.0% |
| Q2 2016 | $7,407,000 | -18.6% | 751,149 | +4.7% | 0.00% | -33.3% |
| Q1 2016 | $9,094,000 | -29.0% | 717,758 | +1.7% | 0.00% | -25.0% |
| Q4 2015 | $12,815,000 | +0.3% | 706,065 | +2.6% | 0.00% | 0.0% |
| Q3 2015 | $12,783,000 | -23.2% | 688,389 | +1.1% | 0.00% | -20.0% |
| Q2 2015 | $16,634,000 | +41.9% | 681,155 | +20.9% | 0.01% | +25.0% |
| Q1 2015 | $11,723,000 | +34.8% | 563,633 | +0.2% | 0.00% | +33.3% |
| Q4 2014 | $8,698,000 | +16.2% | 562,255 | -2.0% | 0.00% | +50.0% |
| Q3 2014 | $7,486,000 | -12.8% | 573,700 | +33.6% | 0.00% | -33.3% |
| Q2 2014 | $8,580,000 | -4.8% | 429,459 | -9.3% | 0.00% | 0.0% |
| Q1 2014 | $9,012,000 | +4.2% | 473,294 | -7.0% | 0.00% | 0.0% |
| Q4 2013 | $8,651,000 | +13.4% | 508,897 | +4.2% | 0.00% | 0.0% |
| Q3 2013 | $7,626,000 | +238.6% | 488,504 | +159.5% | 0.00% | +200.0% |
| Q2 2013 | $2,252,000 | – | 188,274 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |